Olympus Corporation operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Olympus with three other
medical equipment manufacturers in Asia:
Japan Lifeline Co., Ltd.
sales of 45.53 billion Japanese Yen [US$409.27 million]
of which 51%
Fukuda Denshi Co., Ltd.
(129.78 billion Japanese Yen [US$1.17 billion]
of which 39%
was Treatment Equipment), and
Nihon Kohden Corporation
(178.80 billion Japanese Yen [US$1.61 billion]
of which 35%
was Biological Information Monitors).
Olympus reported sales of ¥793.86 billion (US$7.14 billion)
March of 2019.
a very small
increase of 0.9%
versus 2018, when the company's sales were ¥786.50 billion.
Sales of Science saw an increase
that was more than double the company's growth rate: sales were up
4.2% in 2019, from
¥100.02 billion to ¥104.23 billion.
Olympus also saw significant increases in sales in
Medical Care (up 2.9% to ¥634.30 billion)
Not all segments of Olympus experienced an increase in sales in 2019:
sales of Other fell 32.4% to ¥6.66 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
Olympus also experienced decreases in sales in
the Video (down 19.3% to ¥48.68 billion)